title: Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
authors.affiliation: Department of Dermatology, Hospital General de Segovia, Segovia, Spain. beacasadoverrier@gmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Casado-Verrier
authors.forename: S
authors.initials: S
authors.lastname: Pérez-Santos
authors.forename: C
authors.initials: C
authors.lastname: Delgado-Mucientes
authors.forename: M
authors.initials: M
authors.lastname: Beato-Merino
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000188:drug therapy; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib